AC2025 Conference Structure

As the European Health Data Space (EHDS) will establish a network of Secure Processing Environments (SPEs) across 27 countries, valuable insights can be drawn from pioneering initiatives that have already built and operated large-scale data platforms. In this session, you will hear from leaders of these data space projects as they share the good practices and lessons they encountered. Their experience should guide the European Commission and Health Data Access Bodies as they define the common specifications for SPE implementation and governance.

Even the best-designed AI systems can be challenging to use in healthcare settings, in particular when it comes to knowing which patients to apply them to, when to trust their outputs, and how much to rely on their recommendations. The EU AI Act now requires organisations to ensure their personnel are competent AI users. But what does that involve in practice? How can individuals and organisations prepare to be properly empowered to use AI confidently?

The European Health Data Space (EHDS) will require all EHR systems across Europe to support the import and export of standardised patient summaries and other core data sets. This represents a major step forward for both national and cross-border continuity of care. Find out how this vision will be implemented in practice and how the quality of exchanged data will be assessed and assured.

Discover how data platforms are tackling the complex task of safeguarding privacy while enabling responsible data access and use. This session will showcase strategies that promote transparency, build public trust, and ensure governing access to both real and synthetic health data. We will also explore emerging good practices in generating synthetic data – designed to reflect real-world patterns while preserving privacy. Hear from some of Europe’s most advanced initiatives.

Digital health technologies (DHT) are rapidly reshaping healthcare, offering innovative ways to deliver care and empowering both patients and health professionals. But as innovation accelerates, conventional DHT assessment methods are struggling to keep up and risk becoming barriers to digital transformation.
Explore the initiatives that are helping health systems accelerate the adoption of innovative DHT, without compromising on safety or quality.

The European Health Data Space (EHDS) will grant every European citizen the right to access and download their own health summary in a standardised and computable format. But what happens next? This session will showcase some European initiatives demonstrating how patient can unlock the potential benefits from their health data.

How will secondary use of health data be managed across Europe in practice? Hear from TEHDAS2 and some of the early health data access bodies as they share their approach to implementing the European Health Data Space (EHDS) framework. This session will explore how access decision will be made and how societal values will shape acceptable secondary data uses.

The methodology and platforms for reusing EHR data in clinical trial workflows are already well established, but adoption across Europe remains uneven. To strengthen Europe’s competitiveness in clinical research, it’s time to broaden implementation. Find out how this scale-up is being driven forward, and what is needed to accelerate the integration of real-world data into clinical research.

How can healthcare organisations assess the quality of their health data, uncover systematic issues, and measure the impact of improvement strategies? This session explores emerging methodologies, including the use of AI, that support continuous data quality improvement. Join us to discover practical tools, real-world examples, and innovations helping organisations turn their data into a reliable asset.

The European Health Data Space (EHDS) introduces a set of responsibilities for a wide range of organisations that hold health data – from hospitals and registries to research projects and industry. These obligations include populating the data catalogue, labelling data quality and utility, declaring proprietary interests, and preparing datasets for delivery to Health Data Access Bodies (HDABs). Come and join this session to get a clear picture of what it means to be an EHDS data holder and what steps organisations should take now to be ready.

Real-world data (RWD) may lack the structure and controlled quality of clinical trials data but it offers vital insights that trial data alone cannot provide. In this session, hear from leading real-world data ecosystems as they share how they are tackling data quality, governance, and validation to ensure that real world evidence can be trusted for critical decision-making, including those made by medicines regulators.

The first version of the European EHR exchange format is now largely defined but caters for the health summary needs of a common majority of patients. How could this fundamental format evolve to more complex use cases, such as paediatric and rare disease care, care planning, and clinical research? Join this session to explore how the exchange format can the extended to better serve diverse healthcare needs while maintaining interoperability and usability across Europe.